Epidemiology of Burkholderia cepacia complex species recovered from cystic fibrosis patients: issues related to patient segregation
- 1 July 2004
- journal article
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 53 (7) , 663-668
- https://doi.org/10.1099/jmm.0.45557-0
Abstract
Studies of the prevalence of Burkholderia cepacia complex species amongst cystic fibrosis (CF) patients in different geographical regions, and the association between cross-infection and putative transmissibility markers, will further our understanding of these organisms and help to address infection-control issues. In this study, B. cepacia complex isolates from CF patients in different regions of Europe were analysed. Isolates were examined for B. cepacia complex species and putative transmissibility markers [cable pilin subunit gene (cblA) and the B. cepacia epidemic strain marker (BCESM)]. Sporadic and cross-infective strains were identified by random amplification of polymorphic DNA (RAPD). In total, 79 % of patients were infected with Burkholderia cenocepacia (genomovar III), 18 % with Burkholderia multivorans (genomovar II) and less than 5 % of patients with B. cepacia (genomovar I), Burkholderia stabilis (genomovar IV) or Burkholderia vietnamiensis (genomovar V). The cblA and BCESM transmissibility markers were only detected in strains of B. cenocepacia. The BCESM was a more sensitive marker for transmissible B. cenocepacia strains than cblA, although sporadic B. cenocepacia strains containing the BCESM, but lacking cblA, were also observed. Furthermore, clusters of cross-infection with transmissibility marker-negative strains of B. multivorans were identified. In conclusion, B. cenocepacia was the greatest cause of cross-infection, and the most widely distributed B. cepacia complex species, within these CF populations. However, cross-infection was not exclusive to B. cenocepacia and cblA and the BCESM were not absolute markers for transmissible B. cenocepacia, or other B. cepacia complex strains. It is therefore suggested that CF centres cohort patients based on the presence or absence of B. cepacia complex infection and not on the basis of transmissibility marker-positive B. cenocepacia as previously suggested.Keywords
This publication has 29 references indexed in Scilit:
- Evidence of transmission ofBurkholderia cepacia,Burkholderia multivoransandBurkholderia dolosaamong persons with cystic fibrosisFEMS Microbiology Letters, 2003
- Genomovar distribution of the Burkholderia cepacia complex differs significantly between Czech and Slovak patients with cystic fibrosisJournal of Medical Microbiology, 2003
- An epidemic Burkholderia cepacia complex strain identified in soilThe Lancet, 2002
- Endemicity and inter-city spread of Burkholderia cepacia genomovar III in cystic fibrosisThe Journal of Pediatrics, 2001
- Infection withBurkholderia cepaciaComplex Genomovars in Patients with Cystic Fibrosis: Virulent Transmissible Strains of Genomovar III Can ReplaceBurkholderia multivoransClinical Infectious Diseases, 2001
- Burkholderia cepacia Complex Infection in Italian Patients with Cystic Fibrosis: Prevalence, Epidemiology, and Genomovar StatusJournal of Clinical Microbiology, 2001
- Disproportionate Distribution of Burkholderia cepacia Complex Species and Transmissibility Markers in Cystic FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Development of rRNA-Based PCR Assays for Identification of Burkholderia cepacia Complex Isolates Recovered from Cystic Fibrosis PatientsJournal of Clinical Microbiology, 1999
- Genomic complexity and plasticity ofBurkholderia cepaciaFEMS Microbiology Letters, 1996
- Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosisThe Lancet, 1993